-
1
-
-
0027222768
-
Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis
-
Peck WA, Burckhardt P, Christiansen C, et al. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94:646-50.
-
(1993)
Am J Med
, vol.94
, pp. 646-650
-
-
Peck, W.A.1
Burckhardt, P.2
Christiansen, C.3
-
2
-
-
0028786315
-
Determinants of reduced survival following hip fracture in men: A controlled, population-based study
-
Poór G, Atkinson EJ, O'Fallon WM, Melton LJ. Determinants of reduced survival following hip fracture in men: a controlled, population-based study. Clin Orthop 1995;319:260-5.
-
(1995)
Clin Orthop
, vol.319
, pp. 260-265
-
-
Poór, G.1
Atkinson, E.J.2
O'Fallon, W.M.3
Melton, L.J.4
-
3
-
-
0027324969
-
Population-based study of survival after osteoporotic fractures
-
Cooper C, Atkinson EJ, Jacobsen SJ, O'Fallon WM, Melton LJ. Population-based study of survival after osteoporotic fractures. Am J Epidemiol 1993;137:1001-5.
-
(1993)
Am J Epidemiol
, vol.137
, pp. 1001-1005
-
-
Cooper, C.1
Atkinson, E.J.2
Jacobsen, S.J.3
O'Fallon, W.M.4
Melton, L.J.5
-
4
-
-
0021717406
-
Relative contributions of aging and estrogen deficiency to postmenopausal bone loss
-
Richelson LS, Wahner HW, Melton LJ III, Riggs BL. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med 1984;311:1273-5.
-
(1984)
N Engl J Med
, vol.311
, pp. 1273-1275
-
-
Richelson, L.S.1
Wahner, H.W.2
Melton III, L.J.3
Riggs, B.L.4
-
5
-
-
0030034911
-
Sex steroids, bone mass, and bone loss: A prospective study of premenopausal, perimenopausal, and postmenopausal women
-
Slemenda C, Longcope C, Peacock M, Hui S, Johnston CC. Sex steroids, bone mass, and bone loss: a prospective study of premenopausal, perimenopausal, and postmenopausal women. J Clin Invest 1996;97:14-21.
-
(1996)
J Clin Invest
, vol.97
, pp. 14-21
-
-
Slemenda, C.1
Longcope, C.2
Peacock, M.3
Hui, S.4
Johnston, C.C.5
-
6
-
-
0031043696
-
High bone turnover is associated with low bone mass and spinal fracture in postmenopausal women
-
Ravn P, Rix M, Andreasen H, Clemmesen B, Bidstrup M, Gunnes M. High bone turnover is associated with low bone mass and spinal fracture in postmenopausal women. Calcif Tissue Int 1997;60:255-60.
-
(1997)
Calcif Tissue Int
, vol.60
, pp. 255-260
-
-
Ravn, P.1
Rix, M.2
Andreasen, H.3
Clemmesen, B.4
Bidstrup, M.5
Gunnes, M.6
-
7
-
-
0019208916
-
Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen
-
Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 1980;303:1195-8.
-
(1980)
N Engl J Med
, vol.303
, pp. 1195-1198
-
-
Weiss, N.S.1
Ure, C.L.2
Ballard, J.H.3
Williams, A.R.4
Daling, J.R.5
-
8
-
-
0019468567
-
Menopausal estrogen therapy and hip fractures
-
Paganini-Hill A, Ross RK, Gerkins VR, Henderson BE, Arthur M, Mack TM. Menopausal estrogen therapy and hip fractures. Ann Intern Med 1981;95:28-31.
-
(1981)
Ann Intern Med
, vol.95
, pp. 28-31
-
-
Paganini-Hill, A.1
Ross, R.K.2
Gerkins, V.R.3
Henderson, B.E.4
Arthur, M.5
Mack, T.M.6
-
9
-
-
0023229530
-
Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study
-
Kiel DP, Felson DT, Anderson JJ, Wilson PW, Moskowitz MA. Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med 1987;317:1169-74.
-
(1987)
N Engl J Med
, vol.317
, pp. 1169-1174
-
-
Kiel, D.P.1
Felson, D.T.2
Anderson, J.J.3
Wilson, P.W.4
Moskowitz, M.A.5
-
10
-
-
0025332828
-
Hormone replacement therapy and the risk for first hip fracture: A prospective, population-based cohort study
-
Naessén T, Persson I, Adami H-O, Bergström R, Bergkvist L. Hormone replacement therapy and the risk for first hip fracture: a prospective, population-based cohort study. Ann Intern Med 1990;113:95-103.
-
(1990)
Ann Intern Med
, vol.113
, pp. 95-103
-
-
Naessén, T.1
Persson, I.2
Adami, H.-O.3
Bergström, R.4
Bergkvist, L.5
-
11
-
-
0021964389
-
Long-term estrogen replacement therapy prevents bone loss and fractures
-
Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 1985;102:319-24.
-
(1985)
Ann Intern Med
, vol.102
, pp. 319-324
-
-
Ettinger, B.1
Genant, H.K.2
Cann, C.E.3
-
12
-
-
0028885330
-
Fracture protection provided by long-term estrogen treatment
-
Maxim P, Ettinger B, Spitalny GM. Fracture protection provided by long-term estrogen treatment. Osteoporos Int 1995;5:23-9.
-
(1995)
Osteoporos Int
, vol.5
, pp. 23-29
-
-
Maxim, P.1
Ettinger, B.2
Spitalny, G.M.3
-
13
-
-
0028860231
-
Estrogen replacement therapy and fractures in older women
-
Study of Osteoporotic Fractures Research Group
-
Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR. Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med 1995;122:9-16.
-
(1995)
Ann Intern Med
, vol.122
, pp. 9-16
-
-
Cauley, J.A.1
Seeley, D.G.2
Ensrud, K.3
Ettinger, B.4
Black, D.5
Cummings, S.R.6
-
14
-
-
0026691295
-
Treatment of postmenopausal osteoporosis with transdermal estrogen
-
Lufkin EG, Wahner HW, O'Fallon WM, et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 1992;117:1-9.
-
(1992)
Ann Intern Med
, vol.117
, pp. 1-9
-
-
Lufkin, E.G.1
Wahner, H.W.2
O'Fallon, W.M.3
-
15
-
-
0023946106
-
Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: A double blind placebo controlled study
-
Munk-Jensen N, Nielsen SP, Obel EB, Eriksen PB. Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: a double blind placebo controlled study. BMJ 1988;296:1150-2.
-
(1988)
BMJ
, vol.296
, pp. 1150-1152
-
-
Munk-Jensen, N.1
Nielsen, S.P.2
Obel, E.B.3
Eriksen, P.B.4
-
16
-
-
0019464605
-
Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy
-
Christiansen C, Christensen MS, Transbøl I. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet 1981;1:459-61.
-
(1981)
Lancet
, vol.1
, pp. 459-461
-
-
Christiansen, C.1
Christensen, M.S.2
Transbøl, I.3
-
17
-
-
0028363006
-
Magnitude and pattern of skeletal response to long term continuous and cyclic sequential oestrogen/progestin treatment
-
Nielsen SP, Bärenholdt O, Hermansen F, Munk-Jensen N. Magnitude and pattern of skeletal response to long term continuous and cyclic sequential oestrogen/progestin treatment. Br J Obstet Gynaecol 1994;101:319-24.
-
(1994)
Br J Obstet Gynaecol
, vol.101
, pp. 319-324
-
-
Nielsen, S.P.1
Bärenholdt, O.2
Hermansen, F.3
Munk-Jensen, N.4
-
18
-
-
0030999333
-
Effects on bone mass after eight years of hormonal replacement therapy
-
Eiken P, Nielsen SP, Kolthoff N. Effects on bone mass after eight years of hormonal replacement therapy. Br J Obstet Gynaecol 1997;104:702-7.
-
(1997)
Br J Obstet Gynaecol
, vol.104
, pp. 702-707
-
-
Eiken, P.1
Nielsen, S.P.2
Kolthoff, N.3
-
19
-
-
0026543449
-
Low-dosage micronized 17β-estradiol prevents bone loss in postmenopausal women
-
Ettinger B, Genant HK, Steiger P, Madvig P. Low-dosage micronized 17β-estradiol prevents bone loss in postmenopausal women. Am J Obstet Gynecol 1992;166:479-88.
-
(1992)
Am J Obstet Gynecol
, vol.166
, pp. 479-488
-
-
Ettinger, B.1
Genant, H.K.2
Steiger, P.3
Madvig, P.4
-
20
-
-
0022412159
-
Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis
-
Christiansen C, Nilas L, Riis BJ, Rødbro P, Deftos L. Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis. Lancet 1985;II: 800-1.
-
(1985)
Lancet
, vol.2
, pp. 800-801
-
-
Christiansen, C.1
Nilas, L.2
Riis, B.J.3
Rødbro, P.4
Deftos, L.5
-
21
-
-
0346344235
-
Prevention of bone loss with alendronate in postmenopausal women under 60 years of age
-
Hosking D, Chilvers CE, Christiansen C, et al. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. N Engl J Med 1998;338:485-92.
-
(1998)
N Engl J Med
, vol.338
, pp. 485-492
-
-
Hosking, D.1
Chilvers, C.E.2
Christiansen, C.3
-
22
-
-
0024997302
-
17β-Estradiol and continuous norethisterone: A unique treatment for established osteoporosis in elderly women
-
Christiansen C, Riis BJ. 17β-Estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women. J Clin Endocrinol Metab 1990;71:836-41.
-
(1990)
J Clin Endocrinol Metab
, vol.71
, pp. 836-841
-
-
Christiansen, C.1
Riis, B.J.2
-
23
-
-
0028618208
-
Compliance to hormone replacement therapy in menopausal women controlled in a third level academic centre
-
Cano A. Compliance to hormone replacement therapy in menopausal women controlled in a third level academic centre. Maturitas 1995;20:91-9.
-
(1995)
Maturitas
, vol.20
, pp. 91-99
-
-
Cano, A.1
-
24
-
-
0027996333
-
Women's concerns with hormone replacement therapy: Compliance issues
-
Hammond CB. Women's concerns with hormone replacement therapy: compliance issues. Fertil Steril 1994;6(Suppl 2):S157-60.
-
(1994)
Fertil Steril
, vol.6
, Issue.2 SUPPL.
-
-
Hammond, C.B.1
-
26
-
-
0032169355
-
Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms?
-
Bærug U, Winge T, Nordland G, Faber-Swensson E, Heldaas K, Norling B, et al. Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms? Climacteric 1998;1:219-28.
-
(1998)
Climacteric
, vol.1
, pp. 219-228
-
-
Bærug, U.1
Winge, T.2
Nordland, G.3
Faber-Swensson, E.4
Heldaas, K.5
Norling, B.6
-
27
-
-
0030007290
-
17β-Estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy
-
Stadberg E, Mattsson L-Å, Uvebrant M. 17β-Estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy. Maturitas 1996;23:31-9.
-
(1996)
Maturitas
, vol.23
, pp. 31-39
-
-
Stadberg, E.1
Mattsson, L.-Å.2
Uvebrant, M.3
-
28
-
-
0028586042
-
Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment
-
Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994;79:1693-1700.
-
(1994)
J Clin Endocrinol Metab
, vol.79
, pp. 1693-1700
-
-
Garnero, P.1
Shih, W.J.2
Gineyts, E.3
Karpf, D.B.4
Delmas, P.D.5
-
29
-
-
0002215221
-
Utility of biochemical markers of bone resorption in osteoporosis
-
Marcus R, Feldman D, Kelsey J, editors. New York: Academic Press
-
Delmas PD, Garnero P. Utility of biochemical markers of bone resorption in osteoporosis. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. New York: Academic Press, 1996:1075-88.
-
(1996)
Osteoporosis
, pp. 1075-1088
-
-
Delmas, P.D.1
Garnero, P.2
-
30
-
-
0025303668
-
Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists?
-
Riis BJ, Christiansen C, Johansen JS, Jacobson J. Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists? J Clin Endocrinol Metab 1990;70:920-4.
-
(1990)
J Clin Endocrinol Metab
, vol.70
, pp. 920-924
-
-
Riis, B.J.1
Christiansen, C.2
Johansen, J.S.3
Jacobson, J.4
|